Home
About
Overview
Sharing Data
ORCID
Help
History (9)
Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation.
Bronchoalveolar macrophage-lymphocyte reactivity in heart-lung transplant recipients.
The expanding use of third-generation aromatase inhibitors: what the general internist needs to know.
Efficacy of tacrolimus in the treatment of refractory rejection in heart and lung transplant recipients.
CYP2D6 genotyping and tamoxifen: an unfinished story in the quest for personalized medicine.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
CYP2D6 genotyping and tamoxifen: an unfinished story in the quest for personalized medicine.
CYP2D6 genotyping and tamoxifen: an unfinished story in the quest for personalized medicine. Semin Oncol. 2011 Apr; 38(2):263-73.
View in:
PubMed
subject areas
Breast Neoplasms
Cytochrome P-450 CYP2D6
Cytochrome P-450 CYP2D6 Inhibitors
Estrogen Antagonists
Female
Genotype
Humans
Precision Medicine
Tamoxifen
authors with profiles
Olufunmilayo Olopade